Exchange Agreements in the Pharmaceuticals Industry

251 Contracts & Agreements

Browse by Company

Accelerated Pharma, Inc. (4 contracts)
ADIAL PHARMACEUTICALS, INC. (1)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (1)
Agra Nutraceuticals Corp (1)
ALIMERA SCIENCES INC (1)
ANI Pharma Inc (3)
Applied BioSciences Corp. (1)
Artemis Therapeutics, Inc. (2)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
AVADEL PHARMACEUTICALS PLC (3)
AXIM BIOTECHNOLOGIES, INC. (1)
AYTU BIOSCIENCE, INC (1)
Baudax Bio, Inc. (1)
Bespoke Extracts, Inc. (7)
Biofrontera Inc. (1)
BioPharmX Corp (2)
Bohai Pharmaceuticals Group, Inc. (1)
Boston Therapeutics, Inc. (2)
Bristol-Myers Squibb (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (2)
CANNAPHARMARX, INC. (2)
Canopy Growth Corp (4)
Celexus, Inc (3)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
CHINA PHARMA HOLDINGS, INC. (1)
China Yongxin Pharmaceuticals Inc. (3)
CLS Holdings USA, Inc. (2)
COLLAGENEX PHARMACEUTICALS INC (1)
Columbia Care Inc. (3)
CorMedix Inc. (5)
Cure Pharmaceutical Holding Corp. (1)
Egalet Corp (2)
ELITE PHARMACEUTICALS INC (1)
Eloxx Pharmaceuticals, Inc. (3)
Endexx Corp (2)
EPHS HOLDINGS, INC. (4)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (8)
Exactus, Inc. (6)
FRONTIER OILFIELD SERVICES INC (2)
GridIron BioNutrients, Inc. (3)
HARROW HEALTH, INC. (2)
Horizon Pharma plc (1)
IMAGING3 INC (1)
INNOVATE BIOPHARMACEUTICALS, INC. (2)
Item 9 Labs Corp. (1)
Jaguar Health, Inc. (13)
Jiangbo Pharmaceuticals, Inc. (1)
Kannalife Inc (1)
Kaya Holdings, Inc. (2)
Kedem Pharmaceuticals Inc. (2)
KEMPHARM, INC (6)
KID CASTLE EDUCATIONAL CORP (2)
Lannett Company, Inc. (2)
Longboard Pharmaceuticals, Inc. (1)
Lotus Pharmaceuticals, Inc. (1)
Mallinckrodt (2)
Marijuana Co of America, Inc. (2)
Mazal Plant Pharmaceuticals, Inc (1)
MedGen, Inc. (2)
Medicine Man Technologies, Inc. (2)
MERA PHARMACEUTICALS INC (1)
MICROCHANNEL TECHNOLOGIES CORP (2)
Milestone Pharmaceuticals Inc. (1)
MJ Holdings, Inc. (1)
MYnd Analytics, Inc. (3)
NEKTAR THERAPEUTICS (9)
NEXIEN BIOPHARMA, INC. (1)
Notis Global, Inc. (1)
OMEROS CORP (1)
One World Pharma, Inc. (1)
OptiNose, Inc. (1)
OSCIENT PHARMACEUTICALS CORP (2)
PaxMedica, Inc. (2)
PetLife Pharmaceuticals, Inc. (1)
Phibro Animal Health Corporation (1)
Pivot Pharmaceuticals Inc. (3)
PLAYERS NETWORK (1)
Prestige Brands Holdings Inc (1)
ProPhase Labs, Inc. (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
QUANTA INC (1)
QUATRX PHARMACEUTICALS CO (1)
RADIENT PHARMACEUTICALS Corp (6)
Rain Therapeutics Inc. (2)
Rani Therapeutics Holdings, Inc. (2)
RELMADA THERAPEUTICS, INC. (2)
RespireRx Pharmaceuticals Inc. (15)
Royalty Pharma plc (5)
SAVIENT PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (3)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
SYNERGY PHARMACEUTICALS, INC. (2)
Terra Tech Corp. (2)
TETRALOGIC PHARMACEUTICALS CORP (4)
TETRAPHASE PHARMACEUTICALS INC (3)
Textmunication Holdings, Inc. (7)
The Medicines Company (1)
VIA Pharmaceuticals, Inc. (2)
Vitality Biopharma, Inc. (4)
WEED, INC. (1)
XERIS PHARMACEUTICALS INC (1)
Zoetis (1)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Amendment and Restatement Agreement to Exchange Agreement among Royalty Pharma Entities and Shareholders (May 2025)

Exchange Agreements

Royalty Pharma plc

Pharmaceuticals

2025

Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 14, 2025)

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2025

Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. for Series J to Series L Preferred Stock

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2025

Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 13, 2025)

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2025

Omeros Corporation and Investor Exchange Agreement (May 12, 2025)

Exchange Agreements

OMEROS CORP

Pharmaceuticals

2025

Exchange Agreement between Innovation1 Biotech Inc. and Holder for Series C-1 Preferred Stock

Exchange Agreements

GridIron BioNutrients, Inc.

Pharmaceuticals

2025

Amendment and Restatement Agreement to Exchange Agreement among Royalty Pharma Entities (December 31, 2024)

Exchange Agreements

Royalty Pharma plc

Pharmaceuticals

2024

Exchange Agreement between One World Products, Inc. and Isiah L. Thomas, III (November 8, 2024)

Exchange Agreements

One World Pharma, Inc.

Pharmaceuticals

2024

Second Amendment to Exchange Agreement by The Cannabist Company Holdings Inc., Nomis Bay Ltd., and BPY Limited

Exchange Agreements

Columbia Care Inc.

Pharmaceuticals

2024

Reformation of Share Exchange Agreement among the Company, Emergent Health Corp. and the Preferred Shareholders of Emergent Health Corp

Exchange Agreements

Textmunication Holdings, Inc.

Pharmaceuticals

2024

First Amendment to Exchange Agreement between The Cannabist Company Holdings Inc., Nomis Bay Ltd., and BPY Limited

Exchange Agreements

Columbia Care Inc.

Pharmaceuticals

2024

Conversion Agreement between Provectus Biopharmaceuticals, Inc. and Dominic Rodrigues (June 21, 2024)

Exchange Agreements

PROVECTUS BIOPHARMACEUTICALS, INC.

Pharmaceuticals

2024

Canopy Growth Corporation Exchange and Subscription Agreement with Investor (May 2, 2024)

Exchange Agreements

Canopy Growth Corp

Pharmaceuticals

2024

Exchange Agreement between Canopy Growth Corporation and Greenstar Canada Investment Limited Partnership (April 18, 2024)

Exchange Agreements

Canopy Growth Corp

Pharmaceuticals

2024

Amendment to Share Exchange Agreement, dated March 18, 2024

Exchange Agreements

Textmunication Holdings, Inc.

Pharmaceuticals

2024

Exchange Agreement between The Cannabist Company Holdings Inc. and Noteholders (Nomis Bay Ltd. and BPY Limited)

Exchange Agreements

Columbia Care Inc.

Pharmaceuticals

2024

Exchange Agreement between Jaguar Health, Inc. and Investor for Warrant-for-Share Exchange

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2024

Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. (March 1, 2024)

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2024

Share Exchange Agreement among Resonate Blends, Inc., Emergent Health Corp., and EMGE Preferred Shareholders (February 20, 2024)

Exchange Agreements

Textmunication Holdings, Inc.

Pharmaceuticals

2024

Exchange Agreement between Emmaus Life Sciences, Inc. and Investors Dated February 21, 2024

Exchange Agreements

MYnd Analytics, Inc.

Pharmaceuticals

2024

Amendment and Preferred Exchange Agreement between Evofem Biosciences, Inc. and Investor

Exchange Agreements

Evofem Biosciences, Inc.

Pharmaceuticals

2023

Exchange Agreement between Emmaus Life Sciences, Inc. and Investors (December 15, 2023)

Exchange Agreements

MYnd Analytics, Inc.

Pharmaceuticals

2023

Warrant Exchange Agreement between Malachite Innovations, Inc. and Warrantholder

Exchange Agreements

Vitality Biopharma, Inc.

Pharmaceuticals

2023

Exchange Agreement between Uptown Capital, LLC and Jaguar Health, Inc. for Series I Convertible Preferred Stock

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2023

Exchange Agreement between Evofem Biosciences, Inc. and Investor for Convertible Notes and Preferred Stock

Exchange Agreements

Evofem Biosciences, Inc.

Pharmaceuticals

2023

Exchange Agreement between Canopy Growth Corporation and Investor Dated June 29, 2023

Exchange Agreements

Canopy Growth Corp

Pharmaceuticals

2023

Exchange Agreement between Jaguar Health, Inc. and Lender for Partitioned Royalty and Series H Convertible Preferred Stock

Exchange Agreements

Jaguar Health, Inc.

Pharmaceuticals

2023

Exchange Agreement between Scopus BioPharma Inc., Duet Biotherapeutics Inc., and Holder for Series W Warrant Cancellation and Share Issuance

Exchange Agreements

Scopus BioPharma Inc.

Pharmaceuticals

2023

Exchange Agreement between Canopy Growth Corporation and Greenstar Canada Investment Limited Partnership (April 13, 2023)

Exchange Agreements

Canopy Growth Corp

Pharmaceuticals

2023

Exchange Agreement between Scopus BioPharma Inc., Duet Biotherapeutics Inc., and Holder for Series W Warrant Cancellation and Share Issuance

Exchange Agreements

Scopus BioPharma Inc.

Pharmaceuticals

2022

Exchange Agreement between Relmada Therapeutics, Inc. and Venrock Healthcare Capital Partners Entities (September 21, 2022)

Exchange Agreements

RELMADA THERAPEUTICS, INC.

Pharmaceuticals

2022

Exchange Agreement between Evofem Biosciences, Inc. and Investor for Senior Subordinated Notes

Exchange Agreements

Evofem Biosciences, Inc.

Pharmaceuticals

2022

Exchange Agreement between Evofem Biosciences, Inc. and Investor for Note-for-Equity Swap and Warrant Waiver

Exchange Agreements

Evofem Biosciences, Inc.

Pharmaceuticals

2022

Exchange Agreement for Avadel Finance Cayman Limited Exchangeable Senior Notes due 2023 for New Notes due 2027

Exchange Agreements

AVADEL PHARMACEUTICALS PLC

Pharmaceuticals

2023

Exchange Agreement between Milestone Pharmaceuticals Inc. and Investors for Pre-Funded Warrants

Exchange Agreements

Milestone Pharmaceuticals Inc.

Pharmaceuticals

2023

Assertio Holdings, Inc. Convertible Notes Exchange Agreement with Noteholders

Exchange Agreements

Assertio Holdings, Inc.

Pharmaceuticals

2023

Exchange Agreement Between Biofrontera Inc. and Option Holder Dated October 25, 2022

Exchange Agreements

Biofrontera Inc.

Pharmaceuticals

2022

Exchange Agreement between PaxMedica, Inc. and Blue Cane Partners, LLC dated August 3, 2022

Exchange Agreements

PaxMedica, Inc.

Pharmaceuticals

2022

Exchange Agreement between PaxMedica, Inc. and Holder for Preferred Stock Conversion

Exchange Agreements

PaxMedica, Inc.

Pharmaceuticals

2022

Share Exchange Agreement between WEED Inc. and Hempirical Genetics, LLC dated May 2, 2022

Exchange Agreements

WEED, INC.

Pharmaceuticals

2022

Category

Industry

Companies

Contracts

Exchange Agreements in the Pharmaceuticals Industry